Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tocilizumab for the Treatment of Familial Mediterranean Fever - A Randomized, Doubleblind, Phase II Proof of Concept Study

NCT03446209 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03446209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03446209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tocilizumab for the Treatment of Familial Mediterranean Fever - A Randomized, Doubleblind, Phase II Proof of Concept Study
Lead sponsor
University Hospital Tuebingen
Phase
Phase 2
Overall status
Completed
Start date
April 23, 2018
Completion date
October 30, 2020
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

familial mediterranean fever